首页 > 最新文献

Interventional Neuroradiology最新文献

英文 中文
Hemorrhagic versus non-hemorrhagic presentation of presumed reversible cerebral vasoconstriction syndrome (RCVS): Presentations and outcomes. 假定可逆性脑血管收缩综合征(RCVS)的出血性与非出血性表现:表现和结果。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-23 DOI: 10.1177/15910199241285501
Adrusht Madapoosi, Laura Stone McGuire, Angelica Fuentes, Mpuekela Tshibangu, Peter Theiss, Tatiana Abou Mrad, Sepideh Amin-Hanjani, Ali Alaraj

Introduction: Reversible cerebral vasoconstriction syndrome (RCVS) can present with hemorrhage, ischemia, or both. We aim to compare the differences in presentation and outcomes between patients with RCVS.

Methods: The hemorrhagic presentation group had 58 patients, and the non-hemorrhagic presentations had 30 patients. Subgroup analysis compared patients with evidence of one or more types of hemorrhage (n = 53), no evidence of hemorrhage or infarction (n = 23), evidence of infarction only (n = 7), and combination of hemorrhage and infarction (n = 5). Clinical and radiographic data were analyzed.

Results: Migraine (p = 0.030) and intracranial tumors (p = 0.004) were more frequent in non-hemorrhagic presentation. Seizures on admission (p = 0.047) and higher than average C-reactive protein (CRP) (p = 0.037) were seen at a higher rate in patients with hemorrhagic presentation. RCVS2 scores were not unexpectedly higher in patients with hemorrhage than non-hemorrhagic presentations (p = 0.010). Outcomes between the hemorrhagic and non-hemorrhagic groups were comparable. Subgroup analysis found a higher subset of patients with opiate use (p = 0.046) in the hemorrhage-only group. Patients with hemorrhage presented with a thunderclap headache (p < 0.001) more often when compared to the other three groups. RCVS2 score was not unexpectedly higher in the hemorrhage-only group compared with the other groups (p = 0.004).

Conclusion: A history of migraines was associated with ischemia, while intracranial tumor was significantly associated with evidence of either an infarct, or no changes on imaging. Exposure to opiates, and seizures or thunderclap headache on presentation were associated with hemorrhage. If our data are reproducible, the RCVS2 score may benefit from inclusion of other, small hemorrhages as criterion for diagnosis for RCVS.

简介:可逆性脑血管收缩综合征(RCVS可逆性脑血管收缩综合征(RCVS)可表现为出血、缺血或两者兼有。我们旨在比较可逆性脑血管收缩综合征患者在表现和预后方面的差异:出血性表现组有 58 名患者,非出血性表现组有 30 名患者。亚组分析比较了有证据显示一种或多种类型出血的患者(53 例)、无证据显示出血或梗死的患者(23 例)、仅有证据显示梗死的患者(7 例)以及合并出血和梗死的患者(5 例)。对临床和影像学数据进行了分析:结果:偏头痛(p = 0.030)和颅内肿瘤(p = 0.004)在非出血表现中更为常见。入院时癫痫发作(p = 0.047)和C反应蛋白(CRP)高于平均值(p = 0.037)的比例在出血性患者中更高。出血性患者的 RCVS2 评分意外地高于非出血性患者(p = 0.010)。出血组和非出血组的结果相当。亚组分析发现,仅出血组中使用鸦片制剂的患者较多(p = 0.046)。出血患者表现为雷鸣般的头痛(P = 0.004):结论:偏头痛病史与缺血有关,而颅内肿瘤则与脑梗塞或影像学无变化的证据明显相关。接触鸦片制剂、癫痫发作或发病时出现雷鸣般的头痛与出血有关。如果我们的数据具有可重复性,那么将其他小出血作为 RCVS 的诊断标准可能会使 RCVS2 评分受益匪浅。
{"title":"Hemorrhagic versus non-hemorrhagic presentation of presumed reversible cerebral vasoconstriction syndrome (RCVS): Presentations and outcomes.","authors":"Adrusht Madapoosi, Laura Stone McGuire, Angelica Fuentes, Mpuekela Tshibangu, Peter Theiss, Tatiana Abou Mrad, Sepideh Amin-Hanjani, Ali Alaraj","doi":"10.1177/15910199241285501","DOIUrl":"https://doi.org/10.1177/15910199241285501","url":null,"abstract":"<p><strong>Introduction: </strong>Reversible cerebral vasoconstriction syndrome (RCVS) can present with hemorrhage, ischemia, or both. We aim to compare the differences in presentation and outcomes between patients with RCVS.</p><p><strong>Methods: </strong>The hemorrhagic presentation group had 58 patients, and the non-hemorrhagic presentations had 30 patients. Subgroup analysis compared patients with evidence of one or more types of hemorrhage (<i>n</i> = 53), no evidence of hemorrhage or infarction (<i>n</i> = 23), evidence of infarction only (<i>n</i> = 7), and combination of hemorrhage and infarction (<i>n</i> = 5). Clinical and radiographic data were analyzed.</p><p><strong>Results: </strong>Migraine (<i>p</i> = 0.030) and intracranial tumors (<i>p</i> = 0.004) were more frequent in non-hemorrhagic presentation. Seizures on admission (<i>p</i> = 0.047) and higher than average C-reactive protein (CRP) (<i>p</i> = 0.037) were seen at a higher rate in patients with hemorrhagic presentation. RCVS2 scores were not unexpectedly higher in patients with hemorrhage than non-hemorrhagic presentations (<i>p</i> = 0.010). Outcomes between the hemorrhagic and non-hemorrhagic groups were comparable. Subgroup analysis found a higher subset of patients with opiate use (<i>p</i> = 0.046) in the hemorrhage-only group. Patients with hemorrhage presented with a thunderclap headache (<i>p</i> < 0.001) more often when compared to the other three groups. RCVS2 score was not unexpectedly higher in the hemorrhage-only group compared with the other groups (<i>p</i> = 0.004).</p><p><strong>Conclusion: </strong>A history of migraines was associated with ischemia, while intracranial tumor was significantly associated with evidence of either an infarct, or no changes on imaging. Exposure to opiates, and seizures or thunderclap headache on presentation were associated with hemorrhage. If our data are reproducible, the RCVS2 score may benefit from inclusion of other, small hemorrhages as criterion for diagnosis for RCVS.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241285501"},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FreeClimb 88 catheter with Tenzing 8 delivery for contact aspiration mechanical thrombectomy of anterior circulation large vessel occlusions. FreeClimb 88 导管配有 Tenzing 8 输送装置,用于前循环大血管闭塞的接触式抽吸机械血栓切除术。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-23 DOI: 10.1177/15910199241284792
Matthew D Alexander, James Caldwell, Shane Sh Lee, Warren T Kim, Joey D English, Jaehyun Kim, Ben J McGuinness, Matthew Page, Nebiyat F Belachew, Jonathan A Grossberg, Daniel Tonetti, Jane Khalife, Hamza Shaikh, Omar Kass-Hout, Marco Colasurdo, Ryan Priest, Bahram Varjavand, Rajkamal S Khangura, Thymur A Chaudhry, Fabio Settecase

Purpose: Contact aspiration mechanical thrombectomy (CAMT) with 0.088-inch catheters may improve first-pass success rates, but delivery of such catheters can be challenging and limit effectiveness. This study examines the initial multicenter experience using the FreeClimb 88 catheter paired with the Tenzing 8 delivery catheter.

Materials and methods: Retrospective analysis was performed of consecutive patients with large vessel occlusion (LVO) of the internal carotid artery (ICA) or M1 segment of the middle cerebral artery treated with off-label CAMT using the FreeClimb 88 and Tenzing 8 at eight sites participating in the early limited release for these devices. Demographic and procedural variables were collected and analyzed with descriptive statistics and multivariable analysis.

Results: Fifty-three consecutive patients were treated. Large vessel occlusion was located in the ICA in 19/53 (35.8%) patients; 34/53 (64.2%) were in the M1 segment. FreeClimb 88 was successfully delivered to the site of occlusion in 50/53 (94.3%) of patients. First-pass TICI 2c or 3 was achieved with FreeClimb 88 delivered by Tenzing 8 in 36 (67.9%) cases. Among cases with successful FreeClimb 88 delivery 9/50 (18.0%) required additional smaller devices to perform thrombectomy of distal occlusions after recanalization of the initial LVO. No complications or symptomatic hemorrhages occurred following thrombectomy.

Conclusion: Contact aspiration mechanical thrombectomy performed for ICA or M1 LVOs using FreeClimb 88 delivered with Tenzing 8 was safe, effective, and efficient in this early experience, with first-pass TICI 2c or 3 was achieved in 68% of patients without procedural complications occurring in any cases.

目的:使用 0.088 英寸导管进行接触式抽吸机械血栓切除术(CAMT)可提高首次成功率,但这种导管的输送可能具有挑战性,并限制了有效性。本研究探讨了使用 FreeClimb 88 导管和 Tenzing 8 输送导管的初步多中心经验:回顾性分析了在 8 个参与早期有限放行这些设备的医疗机构使用 FreeClimb 88 和 Tenzing 8 进行标签外 CAMT 治疗的颈内动脉 (ICA) 或大脑中动脉 M1 段大血管闭塞 (LVO) 连续患者的情况。研究人员收集了人口统计学和手术变量,并进行了描述性统计和多变量分析:连续治疗了 53 例患者。19/53(35.8%)例患者的大血管闭塞位于ICA;34/53(64.2%)例患者的大血管闭塞位于M1段。有 50/53 名患者(94.3%)成功将 FreeClimb 88 送至闭塞部位。有 36 例(67.9%)患者通过 Tenzing 8 FreeClimb 88 实现了首次 TICI 2c 或 3。在成功使用 FreeClimb 88 的病例中,9/50(18.0%)的患者在对最初的 LVO 进行再通之后,需要使用其他更小的设备对远端闭塞进行血栓切除。血栓切除术后未出现并发症或症状性出血:结论:使用FreeClimb 88和Tenzing 8对ICA或M1 LVO进行接触抽吸式机械血栓切除术是安全、有效和高效的。
{"title":"FreeClimb 88 catheter with Tenzing 8 delivery for contact aspiration mechanical thrombectomy of anterior circulation large vessel occlusions.","authors":"Matthew D Alexander, James Caldwell, Shane Sh Lee, Warren T Kim, Joey D English, Jaehyun Kim, Ben J McGuinness, Matthew Page, Nebiyat F Belachew, Jonathan A Grossberg, Daniel Tonetti, Jane Khalife, Hamza Shaikh, Omar Kass-Hout, Marco Colasurdo, Ryan Priest, Bahram Varjavand, Rajkamal S Khangura, Thymur A Chaudhry, Fabio Settecase","doi":"10.1177/15910199241284792","DOIUrl":"10.1177/15910199241284792","url":null,"abstract":"<p><strong>Purpose: </strong>Contact aspiration mechanical thrombectomy (CAMT) with 0.088-inch catheters may improve first-pass success rates, but delivery of such catheters can be challenging and limit effectiveness. This study examines the initial multicenter experience using the FreeClimb 88 catheter paired with the Tenzing 8 delivery catheter.</p><p><strong>Materials and methods: </strong>Retrospective analysis was performed of consecutive patients with large vessel occlusion (LVO) of the internal carotid artery (ICA) or M1 segment of the middle cerebral artery treated with off-label CAMT using the FreeClimb 88 and Tenzing 8 at eight sites participating in the early limited release for these devices. Demographic and procedural variables were collected and analyzed with descriptive statistics and multivariable analysis.</p><p><strong>Results: </strong>Fifty-three consecutive patients were treated. Large vessel occlusion was located in the ICA in 19/53 (35.8%) patients; 34/53 (64.2%) were in the M1 segment. FreeClimb 88 was successfully delivered to the site of occlusion in 50/53 (94.3%) of patients. First-pass TICI 2c or 3 was achieved with FreeClimb 88 delivered by Tenzing 8 in 36 (67.9%) cases. Among cases with successful FreeClimb 88 delivery 9/50 (18.0%) required additional smaller devices to perform thrombectomy of distal occlusions after recanalization of the initial LVO. No complications or symptomatic hemorrhages occurred following thrombectomy.</p><p><strong>Conclusion: </strong>Contact aspiration mechanical thrombectomy performed for ICA or M1 LVOs using FreeClimb 88 delivered with Tenzing 8 was safe, effective, and efficient in this early experience, with first-pass TICI 2c or 3 was achieved in 68% of patients without procedural complications occurring in any cases.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241284792"},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline embolization device as a standalone curative approach for recurrent sigmoid sinus DAVF. 将管道栓塞装置作为治疗复发性乙状窦 DAVF 的独立方法。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-23 DOI: 10.1177/15910199241282780
Vera Sharashidze, Charlotte Chung, Peter Kim Nelson, Maksim Shapiro, Howard Riina, Erez Nossek, Eytan Raz

Dural arteriovenous fistulas (dAVFs) can occur as complications after surgical procedures, especially following the resection of meningiomas near the dural sinus. This case report presents a 74-year-old male who developed a recurrent sigmoid dAVF following meningioma resection. Initially treated with transvenous embolization and middle meningeal artery embolization, the dAVF recurred with worsening clinical symptoms. Conventional treatment options, including sinus sacrifice and transarterial embolization, were unsuitable due to the critical role of the patient's dominant right sigmoid sinus in cerebral venous drainage. Consequently, a reconstructive approach was employed using a pipeline embolization device (PED) construct. The PED successfully occluded the dAVF while preserving the function of the sigmoid sinus. A follow-up angiogram confirmed stable occlusion and normalization of intracranial venous drainage. This case underscores the potential of flow diversion as a viable treatment option for dAVFs, particularly in scenarios where preserving venous sinus function is paramount.

硬脑膜动静脉瘘(dAVF)可作为外科手术后的并发症出现,尤其是在切除硬脑膜窦附近的脑膜瘤后。本病例报告的患者是一名 74 岁的男性,在脑膜瘤切除术后复发了乙状结肠动静脉瘘。该患者最初接受了经静脉栓塞和脑膜中动脉栓塞治疗,但随着临床症状的恶化,腹腔积液再次复发。由于患者的右乙状窦在脑静脉引流中起着关键作用,因此包括窦牺牲和经动脉栓塞在内的常规治疗方案并不合适。因此,医生采用了管道栓塞装置(PED)进行重建。PED 成功堵塞了 dAVF,同时保留了乙状窦的功能。随访血管造影证实闭塞稳定,颅内静脉引流正常。该病例强调了血流分流作为一种可行的 dAVF 治疗方案的潜力,尤其是在保留静脉窦功能至关重要的情况下。
{"title":"Pipeline embolization device as a standalone curative approach for recurrent sigmoid sinus DAVF.","authors":"Vera Sharashidze, Charlotte Chung, Peter Kim Nelson, Maksim Shapiro, Howard Riina, Erez Nossek, Eytan Raz","doi":"10.1177/15910199241282780","DOIUrl":"10.1177/15910199241282780","url":null,"abstract":"<p><p>Dural arteriovenous fistulas (dAVFs) can occur as complications after surgical procedures, especially following the resection of meningiomas near the dural sinus. This case report presents a 74-year-old male who developed a recurrent sigmoid dAVF following meningioma resection. Initially treated with transvenous embolization and middle meningeal artery embolization, the dAVF recurred with worsening clinical symptoms. Conventional treatment options, including sinus sacrifice and transarterial embolization, were unsuitable due to the critical role of the patient's dominant right sigmoid sinus in cerebral venous drainage. Consequently, a reconstructive approach was employed using a pipeline embolization device (PED) construct. The PED successfully occluded the dAVF while preserving the function of the sigmoid sinus. A follow-up angiogram confirmed stable occlusion and normalization of intracranial venous drainage. This case underscores the potential of flow diversion as a viable treatment option for dAVFs, particularly in scenarios where preserving venous sinus function is paramount.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241282780"},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559946/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some minutes matter more: Groin-to-recanalization is the main time-related predictor of outcome in acute ischemic stroke. 有些分钟更重要腹股沟到肾盂成形术是预测急性缺血性中风预后的主要时间因素。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-23 DOI: 10.1177/15910199241282714
Antonio De Mase, Emanuele Spina, Giovanna Servillo, Stefano Barbato, Giuseppe Leone, Flavio Giordano, Rosaria Renna, Angelo Ranieri, Walter Di Iorio, Massimo Muto, Gianluigi Guarnieri, Mario Muto, Paolo Candelaresi, Vincenzo Andreone

Introduction: Endovascular thrombectomy (EVT) is the standard of care for selected patients with acute ischemic stroke (AIS) and large vessel occlusion (LVO), associated with intravenous thrombolysis, when indicated. While many studies focused on pre-hospital and in-hospital pathways, only few analyzed the relationship between groin-to-recanalization (GTR) time and functional outcome.

Aim: To explore whether GTR time is an independent predictor of outcome in patients undergoing EVT.

Methods: All patients with anterior circulation stroke treated with EVT at a high-volume center from January 2021 to December 2023 were included. The cohort was divided into two groups according to GTR time shorter or longer than 30 min. Regression analysis assessed the association between GTR time and 3-month good outcome, defined as modified Rankin Scale 0-2.

Results: The study included 419 patients. The groups had similar baseline characteristics and similar onset to recanalization (OTR) time. Regression analysis showed shorter GTR time is an independent predictor of favorable outcome (OR 2.49 [95% CI 1.26-4.94]). Age, baseline NIHSS, ASPECT score and bridging IVT were also found to be independently associated with outcome.

Discussion and conclusions: Our study showed GTR time is an independent predictor of good outcome in patients undergoing EVT with similar OTR time, emphasizing procedural time as a key prognostic factor, even greater than other well-known pre-hospital and in-hospital time-dependent variables. These findings may raise the issue of developing alternative approaches or early "rescue" strategies for complicated procedures.

导言:血管内血栓切除术(EVT)是治疗部分急性缺血性卒中(AIS)和大血管闭塞(LVO)患者的标准方法,在有指征的情况下可配合静脉溶栓治疗。许多研究关注院前和院内路径,但只有少数研究分析了腹股沟到再狭窄(GTR)时间与功能预后之间的关系。目的:探讨GTR时间是否是预测接受EVT患者预后的独立指标:方法:纳入2021年1月至2023年12月期间在一家高容量中心接受EVT治疗的所有前循环卒中患者。根据 GTR 时间短于或长于 30 分钟将患者分为两组。回归分析评估了GTR时间与3个月良好预后(定义为改良Rankin量表0-2)之间的关系:研究纳入了 419 名患者。结果:研究共纳入了 419 名患者,两组患者的基线特征相似,起始至再通(OTR)时间相似。回归分析显示,较短的 GTR 时间是良好预后的独立预测因素(OR 2.49 [95% CI 1.26-4.94])。年龄、基线 NIHSS、ASPECT 评分和桥接 IVT 也被发现与预后独立相关:我们的研究表明,GTR时间是在OTR时间相似的情况下进行EVT的患者获得良好预后的独立预测因素,这强调了手术时间是一个关键的预后因素,甚至大于其他众所周知的院前和院内时间依赖变量。这些发现可能提出了为复杂手术开发替代方法或早期 "抢救 "策略的问题。
{"title":"Some minutes matter more: Groin-to-recanalization is the main time-related predictor of outcome in acute ischemic stroke.","authors":"Antonio De Mase, Emanuele Spina, Giovanna Servillo, Stefano Barbato, Giuseppe Leone, Flavio Giordano, Rosaria Renna, Angelo Ranieri, Walter Di Iorio, Massimo Muto, Gianluigi Guarnieri, Mario Muto, Paolo Candelaresi, Vincenzo Andreone","doi":"10.1177/15910199241282714","DOIUrl":"10.1177/15910199241282714","url":null,"abstract":"<p><strong>Introduction: </strong>Endovascular thrombectomy (EVT) is the standard of care for selected patients with acute ischemic stroke (AIS) and large vessel occlusion (LVO), associated with intravenous thrombolysis, when indicated. While many studies focused on pre-hospital and in-hospital pathways, only few analyzed the relationship between groin-to-recanalization (GTR) time and functional outcome.</p><p><strong>Aim: </strong>To explore whether GTR time is an independent predictor of outcome in patients undergoing EVT.</p><p><strong>Methods: </strong>All patients with anterior circulation stroke treated with EVT at a high-volume center from January 2021 to December 2023 were included. The cohort was divided into two groups according to GTR time shorter or longer than 30 min. Regression analysis assessed the association between GTR time and 3-month good outcome, defined as modified Rankin Scale 0-2.</p><p><strong>Results: </strong>The study included 419 patients. The groups had similar baseline characteristics and similar onset to recanalization (OTR) time. Regression analysis showed shorter GTR time is an independent predictor of favorable outcome (OR 2.49 [95% CI 1.26-4.94]). Age, baseline NIHSS, ASPECT score and bridging IVT were also found to be independently associated with outcome.</p><p><strong>Discussion and conclusions: </strong>Our study showed GTR time is an independent predictor of good outcome in patients undergoing EVT with similar OTR time, emphasizing procedural time as a key prognostic factor, even greater than other well-known pre-hospital and in-hospital time-dependent variables. These findings may raise the issue of developing alternative approaches or early \"rescue\" strategies for complicated procedures.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241282714"},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous sinus stenosis intracranial hypertension, rethinking idiopathic intracranial hypertension in the setting of venous sinus stenosis: A call for new nomenclature and diagnostic precision. 静脉窦狭窄性颅内高压症,重新思考静脉窦狭窄情况下的特发性颅内高压症:要求新的命名和诊断精确性。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-23 DOI: 10.1177/15910199241285754
Tatiana Abou-Mrad, Ali Alaraj

Idiopathic intracranial hypertension (IIH) is traditionally characterized by elevated intracranial pressure without an identifiable cause, primarily affecting obese women. However, recent evidence suggests that venous sinus stenosis may play a significant role in the pathophysiology of IIH, challenging its designation as "idiopathic." This editorial discusses the limitations of the current nomenclatures and diagnostic criteria, highlighting the importance of routine venography in detecting venous sinus abnormalities, irrespective of a patient's demographic profile. We propose a new nomenclature of this subset of patients to venous sinus stenosis intracranial hypertension in order to promote more accurate diagnosis and targeted treatment, including potential endovascular interventions.

特发性颅内高压症(IIH)的传统特点是颅内压升高,但无法确定病因,主要影响肥胖女性。然而,最近的证据表明,静脉窦狭窄可能在 IIH 的病理生理学中起着重要作用,从而对其 "特发性 "的称谓提出了质疑。这篇社论讨论了当前命名方法和诊断标准的局限性,强调了常规静脉造影在检测静脉窦异常方面的重要性,无论患者的人口统计学特征如何。我们建议将这部分患者命名为静脉窦狭窄性颅内高压症,以促进更准确的诊断和更有针对性的治疗,包括潜在的血管内介入治疗。
{"title":"Venous sinus stenosis intracranial hypertension, rethinking idiopathic intracranial hypertension in the setting of venous sinus stenosis: A call for new nomenclature and diagnostic precision.","authors":"Tatiana Abou-Mrad, Ali Alaraj","doi":"10.1177/15910199241285754","DOIUrl":"10.1177/15910199241285754","url":null,"abstract":"<p><p>Idiopathic intracranial hypertension (IIH) is traditionally characterized by elevated intracranial pressure without an identifiable cause, primarily affecting obese women. However, recent evidence suggests that venous sinus stenosis may play a significant role in the pathophysiology of IIH, challenging its designation as \"idiopathic.\" This editorial discusses the limitations of the current nomenclatures and diagnostic criteria, highlighting the importance of routine venography in detecting venous sinus abnormalities, irrespective of a patient's demographic profile. We propose a new nomenclature of this subset of patients to venous sinus stenosis intracranial hypertension in order to promote more accurate diagnosis and targeted treatment, including potential endovascular interventions.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241285754"},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the imaging performance of time-of-flight MRA and ultrashort echo time MRA in flow diverters: A phantom study. 飞行时间 MRA 和超短回波时间 MRA 在血流分流器中的成像性能比较:模型研究
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-23 DOI: 10.1177/15910199241285471
Toshiya Akatsu, Akihiko Wada, Michimasa Suzuki, Haruyuki Fukuchi, Yutaka Ikenouchi, Nao Takano, Fumihiro Yagisawa, Kosuke Teranishi, Akira Ishii, Akihide Kondo, Shigeki Aoki

Objective: Flow diverters (FD) are innovative treatments for wide-neck intracranial aneurysms. After-treatment verification of embolization and parent vessel patency is crucial. While evaluation using time-of-flight magnetic resonance angiography (TOF-MRA) is useful, it suffers from signal loss within the FD due to susceptibility effects. This study evaluates the usefulness of ultrashort echo time MRA (UTE-MRA) for after-FD assessment compared to TOF-MRA.

Methods: Vascular phantom experiments were conducted using FDs (FRED®, Pipeline®, Surpass Streamline®). TOF-MRA and UTE-MRA were performed under steady (10, 30, 50 cm/s) and pulsatile (17-61 cm/s, mean 34 cm/s) flow conditions using a 3 T MRI system. As evaluation metrics, relative in-FD signal (RIS) was calculated by comparing the signal intensity inside the FD to that without the FD to assess signal retention, and FD luminal to background signal ratio (FD-LBR) was calculated by comparing the signal intensity inside the FD to that of the surrounding background to evaluate vessel visibility.

Results: UTE-MRA showed higher FD-LBR values than TOF-MRA for all FDs (p < 0.01). For RIS, UTE-MRA was significantly higher for FRED® (p < 0.01), but different for other FDs except at 50 cm/s. FRED® exhibited the highest RIS and FD-LBR values under all conditions, followed by Pipeline® and Surpass Streamline®. Flow velocity changes resulted in minimal variations in RIS and FD-LBR values.

Conclusion: UTE-MRA provides superior image quality for after-FD assessment, particularly in terms of FD-LBR, compared to TOF-MRA. Differences in FD materials and structures affect image quality. These findings suggest UTE-MRA's clinical utility in follow-up after-FD assessment.

目的:血流分流器(FD)是治疗颅内宽颈动脉瘤的创新疗法。治疗后栓塞和母血管通畅的验证至关重要。虽然使用飞行时间磁共振血管造影术(TOF-MRA)进行评估很有用,但由于易感性效应,它在 FD 内会出现信号丢失。与 TOF-MRA 相比,本研究评估了超短回波时间 MRA(UTE-MRA)在 FD 后评估中的实用性:方法:使用 FD(FRED®、Pipeline®、Surpass Streamline®)进行血管模型实验。使用 3 T MRI 系统在稳定(10、30、50 厘米/秒)和脉冲(17-61 厘米/秒,平均 34 厘米/秒)流条件下进行 TOF-MRA 和 UTE-MRA。作为评估指标,相对 FD 内信号(RIS)是通过比较 FD 内和 FD 外的信号强度来计算的,以评估信号保留情况;FD 管腔与背景信号比(FD-LBR)是通过比较 FD 内和周围背景的信号强度来计算的,以评估血管能见度:结果:UTE-MRA显示所有FD的FD-LBR值均高于TOF-MRA(p ® (p ®在所有条件下均显示出最高的RIS和FD-LBR值,其次是Pipeline®和Surpass Streamline®。流速变化导致的 RIS 和 FD-LBR 值变化极小:结论:与 TOF-MRA 相比,UTE-MRA 可为 FD 后评估提供更优越的图像质量,尤其是在 FD-LBR 方面。FD 材料和结构的差异会影响图像质量。这些发现表明,UTE-MRA 在 FD 后随访评估中具有临床实用性。
{"title":"Comparison of the imaging performance of time-of-flight MRA and ultrashort echo time MRA in flow diverters: A phantom study.","authors":"Toshiya Akatsu, Akihiko Wada, Michimasa Suzuki, Haruyuki Fukuchi, Yutaka Ikenouchi, Nao Takano, Fumihiro Yagisawa, Kosuke Teranishi, Akira Ishii, Akihide Kondo, Shigeki Aoki","doi":"10.1177/15910199241285471","DOIUrl":"10.1177/15910199241285471","url":null,"abstract":"<p><strong>Objective: </strong>Flow diverters (FD) are innovative treatments for wide-neck intracranial aneurysms. After-treatment verification of embolization and parent vessel patency is crucial. While evaluation using time-of-flight magnetic resonance angiography (TOF-MRA) is useful, it suffers from signal loss within the FD due to susceptibility effects. This study evaluates the usefulness of ultrashort echo time MRA (UTE-MRA) for after-FD assessment compared to TOF-MRA.</p><p><strong>Methods: </strong>Vascular phantom experiments were conducted using FDs (FRED<sup>®</sup>, Pipeline<sup>®</sup>, Surpass Streamline<sup>®</sup>). TOF-MRA and UTE-MRA were performed under steady (10, 30, 50 cm/s) and pulsatile (17-61 cm/s, mean 34 cm/s) flow conditions using a 3 T MRI system. As evaluation metrics, relative in-FD signal (RIS) was calculated by comparing the signal intensity inside the FD to that without the FD to assess signal retention, and FD luminal to background signal ratio (FD-LBR) was calculated by comparing the signal intensity inside the FD to that of the surrounding background to evaluate vessel visibility.</p><p><strong>Results: </strong>UTE-MRA showed higher FD-LBR values than TOF-MRA for all FDs (<i>p</i> < 0.01). For RIS, UTE-MRA was significantly higher for FRED<sup>®</sup> (<i>p</i> < 0.01), but different for other FDs except at 50 cm/s. FRED<sup>®</sup> exhibited the highest RIS and FD-LBR values under all conditions, followed by Pipeline<sup>®</sup> and Surpass Streamline<sup>®</sup>. Flow velocity changes resulted in minimal variations in RIS and FD-LBR values.</p><p><strong>Conclusion: </strong>UTE-MRA provides superior image quality for after-FD assessment, particularly in terms of FD-LBR, compared to TOF-MRA. Differences in FD materials and structures affect image quality. These findings suggest UTE-MRA's clinical utility in follow-up after-FD assessment.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241285471"},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selective intra-arterial hypothermia combined with endovascular thrombectomy for large vessel occlusion: A systematic review and meta-analysis. 选择性动脉内低温疗法联合血管内血栓切除术治疗大血管闭塞:系统回顾和荟萃分析。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-19 DOI: 10.1177/15910199241285157
Fahad Alturki,Ahmed Alkhiri,Bander Alsulami,Fawaz F Alotaibi,Aser F Alamri,Bader AlRuhaymi,Elyas M Bakhuraybah,Fahad S Al-Ajlan,Adel Alhazzani,Mohammed A Almekhlafi
BACKGROUNDSystemic therapeutic hypothermia may improve outcomes after acute ischemic stroke but increases complications. Selective intra-arterial hypothermia at the ischemic site during endovascular thrombectomy (EVT) theoretically offers benefits with fewer risks. However, there is little clinical evidence to support this approach.METHODSWe searched Medline/PubMed, Embase and Cochrane electronic databases for studies evaluating the safety and feasibility of selective intra-arterial hypothermia as an adjunct to EVT for large vessel occlusion (LVO). Effect sizes with 95% confidence intervals (CIs) were pooled using the fixed-effect model. Odds ratios (ORs) were computed for binary variables, while the mean differences (MDs) were pooled for continuous data.RESULTSOf identified records, five clinical studies involving 463 LVO patients (62.9% male) were included. Of those, 224 (48.4%) patients received adjuvant selective intra-arterial hypothermia, while 239 (51.6%) received EVT alone. Selective intra-arterial hypothermia resulted in higher rates of good functional outcome (modified Rankin scale [mRS] 0-2 at 90-days) (OR 2.07, [95% CI, 1.36 to 3.16]), and lower final infarct volume (MD, -20.96 ml [95% CI, -26.17 to -15.75]) and lower rates of severe disability (mRS 3-5 at 90 days) (OR 0.44 [95% CI, 0.26 to 0.75]). Safety parameters including rates of symptomatic intracerebral hemorrhage, mortality, pneumonia, coagulation abnormalities, and arterial spasm were comparable between groups.CONCLUSIONSThe initial evidence supports the safety and feasibility of selective intra-arterial hypothermia when combined with EVT for LVO. This approach shows promise for advancing research on neuroprotective strategies for ischemic stroke.
背景系统性治疗性低温可改善急性缺血性中风后的预后,但会增加并发症。理论上,在血管内血栓切除术(EVT)中对缺血部位进行选择性动脉内低温治疗可降低风险,带来益处。我们在 Medline/PubMed、Embase 和 Cochrane 电子数据库中检索了评估选择性动脉内低温疗法作为大血管闭塞 (LVO) EVT 辅助疗法的安全性和可行性的研究。采用固定效应模型对效应大小和 95% 置信区间 (CI) 进行了汇总。对二进制变量计算了比值比(ORs),而对连续性数据则汇总了平均差(MDs)。其中,224 例(48.4%)患者接受了选择性动脉内低温辅助治疗,239 例(51.6%)患者仅接受了 EVT 治疗。选择性动脉内低温治疗可提高良好功能预后率(90天时改良Rankin量表[mRS] 0-2)(OR 2.07 [95% CI, 1.36 to 3.16]),降低最终梗死体积(MD, -20.96 ml [95% CI, -26.17 to -15.75])和严重残疾率(90天时mRS 3-5)(OR 0.44 [95% CI, 0.26 to 0.75])。包括无症状脑出血、死亡率、肺炎、凝血异常和动脉痉挛发生率在内的安全性参数在各组之间具有可比性。结论:初步证据支持选择性动脉内低温治疗与 EVT 联合治疗 LVO 的安全性和可行性。这种方法有望推动缺血性脑卒中神经保护策略的研究。
{"title":"Selective intra-arterial hypothermia combined with endovascular thrombectomy for large vessel occlusion: A systematic review and meta-analysis.","authors":"Fahad Alturki,Ahmed Alkhiri,Bander Alsulami,Fawaz F Alotaibi,Aser F Alamri,Bader AlRuhaymi,Elyas M Bakhuraybah,Fahad S Al-Ajlan,Adel Alhazzani,Mohammed A Almekhlafi","doi":"10.1177/15910199241285157","DOIUrl":"https://doi.org/10.1177/15910199241285157","url":null,"abstract":"BACKGROUNDSystemic therapeutic hypothermia may improve outcomes after acute ischemic stroke but increases complications. Selective intra-arterial hypothermia at the ischemic site during endovascular thrombectomy (EVT) theoretically offers benefits with fewer risks. However, there is little clinical evidence to support this approach.METHODSWe searched Medline/PubMed, Embase and Cochrane electronic databases for studies evaluating the safety and feasibility of selective intra-arterial hypothermia as an adjunct to EVT for large vessel occlusion (LVO). Effect sizes with 95% confidence intervals (CIs) were pooled using the fixed-effect model. Odds ratios (ORs) were computed for binary variables, while the mean differences (MDs) were pooled for continuous data.RESULTSOf identified records, five clinical studies involving 463 LVO patients (62.9% male) were included. Of those, 224 (48.4%) patients received adjuvant selective intra-arterial hypothermia, while 239 (51.6%) received EVT alone. Selective intra-arterial hypothermia resulted in higher rates of good functional outcome (modified Rankin scale [mRS] 0-2 at 90-days) (OR 2.07, [95% CI, 1.36 to 3.16]), and lower final infarct volume (MD, -20.96 ml [95% CI, -26.17 to -15.75]) and lower rates of severe disability (mRS 3-5 at 90 days) (OR 0.44 [95% CI, 0.26 to 0.75]). Safety parameters including rates of symptomatic intracerebral hemorrhage, mortality, pneumonia, coagulation abnormalities, and arterial spasm were comparable between groups.CONCLUSIONSThe initial evidence supports the safety and feasibility of selective intra-arterial hypothermia when combined with EVT for LVO. This approach shows promise for advancing research on neuroprotective strategies for ischemic stroke.","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":"49 1","pages":"15910199241285157"},"PeriodicalIF":1.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous sinus diverticulum in patients with pulsatile tinnitus: An acquired lesion. 搏动性耳鸣患者的静脉窦憩室:后天性病变
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-19 DOI: 10.1177/15910199241272645
Mohamad Abdalkader,Piers Klein,Avner Aliphas,Peter Weber,Thanh N Nguyen
BACKGROUNDThe etiopathogenesis of venous sinus diverticulum is controversial. Conflicting evidence has been published suggesting that venous sinus diverticulum is either a congenital or acquired lesion.METHODSThis is a case report of a single individual followed for 17 years within a single healthcare system.RESULTSAn early middle-aged woman presented with unilateral pulsatile tinnitus, vertigo, and decreased hearing. Initial imaging was unrevealing. Interval imaging after 13 years revealed the development of an ipsilateral venous sinus diverticulum. The patient was treated via endovascular stenting and coiling of the lesion with complete resolution of symptoms.CONCLUSIONSWe demonstrate that a venous sinus diverticulum in a patient with pulsatile tinnitus is an acquired lesion. Further research is warranted to better elucidate the precise etiology and pathophysiology of acquired venous sinus diverticulum, potentially guiding management strategies.
背景静脉窦憩室的发病机制存在争议。已有证据表明静脉窦憩室是一种先天性或后天性病变。方法这是一份病例报告,在单一医疗系统内对一名患者进行了长达 17 年的随访。最初的影像学检查未发现异常。13 年后的间隔成像显示,同侧静脉窦出现憩室。我们的结论表明,搏动性耳鸣患者的静脉窦憩室是一种获得性病变。为了更好地阐明获得性静脉窦憩室的确切病因和病理生理学,我们有必要开展进一步的研究,从而为治疗策略提供指导。
{"title":"Venous sinus diverticulum in patients with pulsatile tinnitus: An acquired lesion.","authors":"Mohamad Abdalkader,Piers Klein,Avner Aliphas,Peter Weber,Thanh N Nguyen","doi":"10.1177/15910199241272645","DOIUrl":"https://doi.org/10.1177/15910199241272645","url":null,"abstract":"BACKGROUNDThe etiopathogenesis of venous sinus diverticulum is controversial. Conflicting evidence has been published suggesting that venous sinus diverticulum is either a congenital or acquired lesion.METHODSThis is a case report of a single individual followed for 17 years within a single healthcare system.RESULTSAn early middle-aged woman presented with unilateral pulsatile tinnitus, vertigo, and decreased hearing. Initial imaging was unrevealing. Interval imaging after 13 years revealed the development of an ipsilateral venous sinus diverticulum. The patient was treated via endovascular stenting and coiling of the lesion with complete resolution of symptoms.CONCLUSIONSWe demonstrate that a venous sinus diverticulum in a patient with pulsatile tinnitus is an acquired lesion. Further research is warranted to better elucidate the precise etiology and pathophysiology of acquired venous sinus diverticulum, potentially guiding management strategies.","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":"65 1","pages":"15910199241272645"},"PeriodicalIF":1.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alternative hybrid access in endovascular neurosurgery: Scoping review and technical considerations 血管内神经外科手术中的替代杂交入路:范围审查和技术考虑因素
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-17 DOI: 10.1177/15910199241282352
Matias Costa, Juan Vivanco-Suarez, Sean O’Leary, Preston D’Souza, Ravi Nunna, Sabino Luzzi, Daniel Casanova-Martinez, Akshal Patel
BackgroundThe common femoral artery and radial artery constitute the most common access sites in contemporaneous endovascular neurosurgery. Oftentimes, it may be impossible to reach the vascular target safely due to different circumstances, necessitating alternative approaches. We aim to review these “last resource” access sites described in the literature, focusing on the technical aspects as a convenient reference.MethodsWe performed a comprehensive literature search of PubMed capturing articles from 1958 to 2022.ResultsWe identified nine alternative approaches for endovascular access, after excluding direct carotid stick: superficial temporal artery access in 60 patients, calvarial foramina access in five patients, occipital artery access in seven patients, middle meningeal artery access in six patients, vertebral artery access in 23 patients and external carotid artery, internal maxillary artery, facial artery or lingual artery in 40 patients. Indications for the use of alternative access points included tortuous or occluded vessels, small vessel calibers, or anatomic variation. Pathologies treated included dural arteriovenous fistulas, arteriovenous malformations, intracranial aneurysms, acute stroke, and intracranial stenosis. Diagnostic brain angiograms were also performed.ConclusionsAlternative vascular access routes expand the proceduralists' toolkit, enhancing the capability to manage complex cerebrovascular interventions. This review advocates for a broader understanding and consideration of these techniques, given their potential to significantly increase treatment options in neuroendovascular surgery.
背景股总动脉和桡动脉是当代血管内神经外科最常见的入路部位。有时,由于情况不同,可能无法安全到达血管靶点,因此需要采用其他方法。我们旨在回顾文献中描述的这些 "最后资源 "入路部位,重点关注技术方面,以方便参考。结果 在排除颈动脉直扎后,我们确定了九种血管内入路的替代方法:60 例患者采用颞浅动脉入路,5 例患者采用犊鼻孔入路,7 例患者采用枕动脉入路,6 例患者采用脑膜中动脉入路,23 例患者采用椎动脉入路,40 例患者采用颈外动脉、颌内动脉、面动脉或舌动脉入路。使用替代接入点的指征包括血管迂曲或闭塞、血管口径小或解剖变异。治疗的病症包括硬脑膜动静脉瘘、动静脉畸形、颅内动脉瘤、急性中风和颅内狭窄。结论替代血管通路扩大了手术医师的工具包,提高了处理复杂脑血管介入的能力。这篇综述主张更广泛地了解和考虑这些技术,因为它们有可能大大增加神经内血管手术的治疗选择。
{"title":"Alternative hybrid access in endovascular neurosurgery: Scoping review and technical considerations","authors":"Matias Costa, Juan Vivanco-Suarez, Sean O’Leary, Preston D’Souza, Ravi Nunna, Sabino Luzzi, Daniel Casanova-Martinez, Akshal Patel","doi":"10.1177/15910199241282352","DOIUrl":"https://doi.org/10.1177/15910199241282352","url":null,"abstract":"BackgroundThe common femoral artery and radial artery constitute the most common access sites in contemporaneous endovascular neurosurgery. Oftentimes, it may be impossible to reach the vascular target safely due to different circumstances, necessitating alternative approaches. We aim to review these “last resource” access sites described in the literature, focusing on the technical aspects as a convenient reference.MethodsWe performed a comprehensive literature search of PubMed capturing articles from 1958 to 2022.ResultsWe identified nine alternative approaches for endovascular access, after excluding direct carotid stick: superficial temporal artery access in 60 patients, calvarial foramina access in five patients, occipital artery access in seven patients, middle meningeal artery access in six patients, vertebral artery access in 23 patients and external carotid artery, internal maxillary artery, facial artery or lingual artery in 40 patients. Indications for the use of alternative access points included tortuous or occluded vessels, small vessel calibers, or anatomic variation. Pathologies treated included dural arteriovenous fistulas, arteriovenous malformations, intracranial aneurysms, acute stroke, and intracranial stenosis. Diagnostic brain angiograms were also performed.ConclusionsAlternative vascular access routes expand the proceduralists' toolkit, enhancing the capability to manage complex cerebrovascular interventions. This review advocates for a broader understanding and consideration of these techniques, given their potential to significantly increase treatment options in neuroendovascular surgery.","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":"14 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1-Year outcomes of Resolute Onyx Zotarolimus-Eluting Stent for symptomatic intracranial atherosclerotic disease: A multicenter propensity score–matched comparison with stenting versus aggressive medical management for preventing recurrent stroke in intracranial stenosis trial Resolute Onyx Zotarolimus洗脱支架治疗无症状颅内动脉粥样硬化疾病的 1 年疗效:为预防颅内狭窄复发中风而进行的支架植入与积极药物治疗的多中心倾向评分匹配比较试验
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2024-09-14 DOI: 10.1177/15910199241278033
Saisree Ravi, Ibrahim A Bhatti, Ravi S Nunna, Syed Khalid, Wondwossen G Tekle, Omar Tanweer, Jan-Karl Burkhardt, Pascal M Jabbour, Stavropoula I Tjoumakaris, Nabeel A Herial, Adnan H Siddiqui, Ramesh Grandhi, Adnan I Qureshi, Farhan Siddiq, Ameer E Hassan
BackgroundIntracranial atherosclerotic disease (ICAD) is one of the most prevalent causes of stroke across the world. Endovascular treatment has gained prominence but remains a challenge with unfavorable results. Recent literature has demonstrated that the Resolute Onyx Zotarolimus-Eluting Stent (RO-ZES) is a technically safe option with low complication rates along with 30-day outcomes associated with intracranial stent placement for ICAD with RO-ZES compared to results from the Stenting Versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Here, we aim to compare outcomes at one year with the SAMMPRIS trial with a multicenter longitudinal study.Materials and methodsProspectively maintained databases across seven stroke centers were analyzed for adult patients undergoing RO-ZES placement for ICAD between January 2019 and May 2023. The primary endpoint was composite of one-year stroke, ICH, and/or death. These data were propensity score matched using age, sex, hypertension, diabetes mellitus, smoking status, and impacted vessel for comparison between RO-ZES and the SAMMPRIS percutaneous angioplasty and stenting groups (S-PTAS).ResultsA total of 104 patients were included, mean age ± SD: 64.9 ± 10.9 years, 25.5% female. Propensity score match analysis of the 104 patients with S-PTAS demonstrated one-year stroke, ICH, and/or death rate of 11.5% in the RO-ZES group and 28.1% in the S-PTAS group (odds ratio 4.17, 95% CI 2.06–8.96, p = 0.001).ConclusionThe RO-ZES system demonstrates strong potential to reduce long-term complications at one year compared with the S-PTAS group. Further prospective multicenter studies are needed to corroborate and build upon these findings.
背景颅内动脉粥样硬化性疾病(ICAD)是全球最常见的脑卒中病因之一。血管内治疗的地位日益突出,但仍是一项挑战,效果并不理想。最近的文献表明,Resolute Onyx Zotarolimus洗脱支架(RO-ZES)是一种技术上安全的选择,并发症发生率低,与颅内支架置入术(RO-ZES)治疗 ICAD 的 30 天疗效相比,颅内支架置入术与积极的药物治疗预防颅内狭窄复发中风(SAMMPRIS)试验的结果也是如此。在此,我们旨在通过一项多中心纵向研究,将一年后的结果与 SAMMPRIS 试验进行比较。材料和方法分析了七个卒中中心的前瞻性数据库,其中包括在 2019 年 1 月至 2023 年 5 月期间接受 RO-ZES 置入术治疗 ICAD 的成年患者。主要终点为一年期中风、ICH 和/或死亡的复合终点。这些数据根据年龄、性别、高血压、糖尿病、吸烟状况和受影响血管进行倾向得分匹配,以便在RO-ZES组和SAMMPRIS经皮血管成形术和支架植入组(S-PTAS)之间进行比较。结果共纳入104例患者,平均年龄(± SD):64.9±10.9岁,25.5%为女性。对 104 名 S-PTAS 患者进行倾向得分匹配分析,结果显示 RO-ZES 组一年内中风、ICH 和/或死亡率为 11.5%,S-PTAS 组为 28.1%(几率比 4.17,95% CI 2.06-8.96,p = 0.001)。需要进一步的前瞻性多中心研究来证实和巩固这些发现。
{"title":"1-Year outcomes of Resolute Onyx Zotarolimus-Eluting Stent for symptomatic intracranial atherosclerotic disease: A multicenter propensity score–matched comparison with stenting versus aggressive medical management for preventing recurrent stroke in intracranial stenosis trial","authors":"Saisree Ravi, Ibrahim A Bhatti, Ravi S Nunna, Syed Khalid, Wondwossen G Tekle, Omar Tanweer, Jan-Karl Burkhardt, Pascal M Jabbour, Stavropoula I Tjoumakaris, Nabeel A Herial, Adnan H Siddiqui, Ramesh Grandhi, Adnan I Qureshi, Farhan Siddiq, Ameer E Hassan","doi":"10.1177/15910199241278033","DOIUrl":"https://doi.org/10.1177/15910199241278033","url":null,"abstract":"BackgroundIntracranial atherosclerotic disease (ICAD) is one of the most prevalent causes of stroke across the world. Endovascular treatment has gained prominence but remains a challenge with unfavorable results. Recent literature has demonstrated that the Resolute Onyx Zotarolimus-Eluting Stent (RO-ZES) is a technically safe option with low complication rates along with 30-day outcomes associated with intracranial stent placement for ICAD with RO-ZES compared to results from the Stenting Versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Here, we aim to compare outcomes at one year with the SAMMPRIS trial with a multicenter longitudinal study.Materials and methodsProspectively maintained databases across seven stroke centers were analyzed for adult patients undergoing RO-ZES placement for ICAD between January 2019 and May 2023. The primary endpoint was composite of one-year stroke, ICH, and/or death. These data were propensity score matched using age, sex, hypertension, diabetes mellitus, smoking status, and impacted vessel for comparison between RO-ZES and the SAMMPRIS percutaneous angioplasty and stenting groups (S-PTAS).ResultsA total of 104 patients were included, mean age ± SD: 64.9 ± 10.9 years, 25.5% female. Propensity score match analysis of the 104 patients with S-PTAS demonstrated one-year stroke, ICH, and/or death rate of 11.5% in the RO-ZES group and 28.1% in the S-PTAS group (odds ratio 4.17, 95% CI 2.06–8.96, p = 0.001).ConclusionThe RO-ZES system demonstrates strong potential to reduce long-term complications at one year compared with the S-PTAS group. Further prospective multicenter studies are needed to corroborate and build upon these findings.","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":"16 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interventional Neuroradiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1